Van Hulzen Asset Management, LLC Shockwave Medical, Inc. Transaction History

Van Hulzen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$191.17 - $325.63 $18,352 - $31,260	96 Added 1.75%	5,567 $1.81 Million
Q4 2023 Feb 07, 2024	SELL	$160.99 - $215.69 $355,626 - $476,459	-2,209 Reduced 28.76%	5,471 $1.04 Million
Q3 2023 Nov 07, 2023	BUY	$194.33 - $283.97 $1.19 Million - $1.74 Million	6,124 Added 393.57%	7,680 $1.53 Million
Q2 2023 Aug 03, 2023	SELL	$223.05 - $302.68 $230,856 - $313,273	-1,035 Reduced 39.95%	1,556 $444,000
Q1 2023 Apr 28, 2023	BUY	$175.41 - $217.92 $454,487 - $564,630	2,591 New	2,591 $562,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.